Diabetic retinopathy: A review on its pathophysiology and novel treatment modalities

World J Methodol. 2024 Dec 20;14(4):95881. doi: 10.5662/wjm.v14.i4.95881.

Abstract

Diabetes mellitus (DM) is a chronic metabolic non-communicable disease with the ability to cause serious microvascular and macrovascular complications throughout the body, including in the eye. Diabetic retinopathy (DR), present in one-third of patients with diabetes, is a vision-threatening complication caused by uncontrolled diabetes, which greatly affects the retinal blood vessels and the light-sensitive inner retina, eventually leading to blindness. Several epidemiological studies elucidate that DR can vary by age of onset, duration, types of diabetes, and ethnicity. Recent studies show that the pathogenesis of diabetic retinopathy has spread its roots beyond merely being the result of hyperglycemia. The complexity of its etiopathology and diagnosis makes therapeutic intervention challenging. This review throws light on the pathological processes behind DR, the cascade of events that follow it, as well as the available and emerging treatment options.

Keywords: Diabetes; Diabetic macular edema; Diabetic retinopathy; Intravitreal injection; Laser photocoagulation.

Publication types

  • Review